It has been claimed GLP-1 drugs like Ozempic and Mounjaro could be available to NHS patients over the counter at pharmacies, according to news reports.
Vespa Capital, a UK private equity firm focused on lower mid-market investments, has invested in FibroFind, a contract research organisation that has a patented technology which enables testing to be carried out on human tissue rather than animals.
French pharma giant Sanofi has announced the closing of the sale to US private equity firm Clayton, Dubilier & Rice (CD&R) of a 50% controlling stake of its consumer healthcare business Opella.
The UK’s Competition and Markets Authority (CMA) has proposed measures to increase price transparency in the UK’s veterinary sector, and even suggested limited price controls. Shares of listed veterinary groups jumped up, however, as the proposed measures did not include much-feared forced asset sales.
Amethyst, a pan-European private cancer care provider specialising in radiotherapy, has been acquired by Fremman Capital, a European private equity firm, from its founding shareholders and The Rohatyn Group (TRG).
Multiple global private equity bidders — including Blackstone, TPG, General Atlantic, and Frazier Healthcare Partners — have been shortlisted for the sale of AGS Health, a healthcare revenue cycle management (RCM) firm owned by Swedish fund EQT Partners, according to Indian media reports.
Fakeeh Care Group, a healthcare service provider in Saudi Arabia, and Fosun Pharma, an innovation-driven global healthcare company, have forged a strategic partnership to advance cell and gene therapy and tele-diagnostics in Saudi Arabia.
Akdital, Morocco’s largest private healthcare provider, is set to expand internationally with a $200 million investment to build two hospitals in Riyadh and Jeddah.
With demand for aesthetics rapidly growing, HBI spoke to Raja K Pitalia, Managing Director of Pall Mall, a private healthcare and cosmetic surgery provider in North West England, about how the company strives to safely meet demand, how the company has evolved, and trends in the sector.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
